Literature DB >> 21125386

Expression of recombinant proteins with uniform N-termini.

Orsolya Király1, Lan Guan, Miklós Sahin-Tóth.   

Abstract

Heterologously expressed proteins in Escherichia coli may undergo unwanted N-terminal processing by methionine and proline aminopeptidases. To overcome this problem, we present a system where the gene of interest is cloned as a fusion to a self-splicing mini-intein. This fusion construct is expressed in an engineered E. coli strain from which the pepP gene coding for aminopeptidase P has been deleted. We describe a protocol using human cationic trypsinogen as an example to demonstrate that recombinant proteins produced in this expression system contain homogeneous, unprocessed N-termini.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21125386      PMCID: PMC3107599          DOI: 10.1007/978-1-61737-967-3_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

1.  The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins.

Authors:  T C Evans; J Benner; M Q Xu
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis.

Authors:  J M Chen; O Raguenes; C Ferec; P H Deprez; C Verellen-Dumoulin; A Andriulli
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

3.  Trypsinogen mutations in chronic pancreatitis.

Authors:  R H Pfützer; D C Whitcomb
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

4.  Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.

Authors:  M Sahin-Tóth; M Tóth
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

5.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  Protein trans-splicing and functional mini-inteins of a cyanobacterial dnaB intein.

Authors:  H Wu; M Q Xu; X Q Liu
Journal:  Biochim Biophys Acta       Date:  1998-09-08

7.  Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.

Authors:  M Sahin-Tóth
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

8.  A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis.

Authors:  H Witt; W Luck; M Becker
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

9.  Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.

Authors:  Niels Teich; Nadine Bauer; Joachim Mössner; Volker Keim
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

10.  Expression of human cationic trypsinogen with an authentic N terminus using intein-mediated splicing in aminopeptidase P deficient Escherichia coli.

Authors:  Orsolya Király; Lan Guan; Edit Szepessy; Miklós Tóth; Zoltán Kukor; Miklós Sahin-Tóth
Journal:  Protein Expr Purif       Date:  2006-02-21       Impact factor: 1.650

View more
  18 in total

1.  Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.

Authors:  András Szabó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.

Authors:  András Szabó; Evette S Radisky; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.

Authors:  Vanda Toldi; András Szabó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2020-02-03       Impact factor: 5.157

4.  Gene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis.

Authors:  Agnieszka Magdalena Rygiel; Sebastian Beer; Peter Simon; Katarzyna Wertheim-Tysarowska; Grzegorz Oracz; Torsten Kucharzik; Andrzej Tysarowski; Katarzyna Niepokój; Jarosław Kierkus; Marta Jurek; Paweł Gawliński; Jarosław Poznański; Jerzy Bal; Markus M Lerch; Miklós Sahin-Tóth; Frank Ulrich Weiss
Journal:  Hum Mutat       Date:  2015-03       Impact factor: 4.878

5.  Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.

Authors:  Andrea Schnúr; Sebastian Beer; Heiko Witt; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Gut       Date:  2013-03-01       Impact factor: 23.059

6.  Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.

Authors:  Zsanett Jancsó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

7.  Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.

Authors:  Andrea Geisz; Péter Hegyi; Miklós Sahin-Tóth
Journal:  FEBS J       Date:  2013-05-16       Impact factor: 5.542

8.  Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.

Authors:  Balázs Csaba Németh; Thomas Wartmann; Walter Halangk; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

9.  Mutation That Promotes Activation of Trypsinogen Increases Severity of Secretagogue-Induced Pancreatitis in Mice.

Authors:  Zsanett Jancsó; Miklós Sahin-Tóth
Journal:  Gastroenterology       Date:  2019-11-18       Impact factor: 22.682

10.  Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.

Authors:  Anita Balázs; Péter Hegyi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.